Soiken Holdings Inc. (2385.T)
JPY 122.0
(-1.61%)
JPY 122.0
(-1.61%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.12 Billion JPY | -13.52% |
| 2022 | 1.29 Billion JPY | 14.52% |
| 2021 | 1.13 Billion JPY | -33.06% |
| 2020 | 1.69 Billion JPY | 22.23% |
| 2019 | 1.38 Billion JPY | 6.18% |
| 2018 | 1.3 Billion JPY | 25.09% |
| 2017 | 1.04 Billion JPY | 36.92% |
| 2016 | 760.63 Million JPY | 86.49% |
| 2015 | 407.85 Million JPY | 11.78% |
| 2014 | 364.87 Million JPY | 1.52% |
| 2013 | 359.41 Million JPY | 33.49% |
| 2012 | 269.24 Million JPY | 19.22% |
| 2011 | 225.83 Million JPY | 18.81% |
| 2010 | 190.07 Million JPY | -12.49% |
| 2009 | 217.21 Million JPY | -24.25% |
| 2008 | 286.73 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q2 | 1.09 Billion JPY | -17.65% |
| 2023 FY | 1.12 Billion JPY | -13.52% |
| 2023 Q3 | 1.14 Billion JPY | 5.01% |
| 2023 Q1 | 1.32 Billion JPY | 2.39% |
| 2023 Q4 | 1.12 Billion JPY | -2.33% |
| 2022 Q1 | 1.25 Billion JPY | 10.61% |
| 2022 FY | 1.29 Billion JPY | 14.52% |
| 2022 Q4 | 1.29 Billion JPY | 15.15% |
| 2022 Q3 | 1.12 Billion JPY | 5.12% |
| 2022 Q2 | 1.07 Billion JPY | -14.47% |
| 2021 Q2 | 1.12 Billion JPY | -0.49% |
| 2021 FY | 1.13 Billion JPY | -33.06% |
| 2021 Q1 | 1.12 Billion JPY | -33.31% |
| 2021 Q4 | 1.13 Billion JPY | -3.85% |
| 2021 Q3 | 1.17 Billion JPY | 4.91% |
| 2020 Q2 | 1.25 Billion JPY | -17.57% |
| 2020 Q3 | 1.38 Billion JPY | 9.81% |
| 2020 FY | 1.69 Billion JPY | 22.23% |
| 2020 Q1 | 1.52 Billion JPY | 10.47% |
| 2020 Q4 | 1.69 Billion JPY | 22.25% |
| 2019 Q4 | 1.38 Billion JPY | -0.86% |
| 2019 FY | 1.38 Billion JPY | 6.18% |
| 2019 Q1 | 1.23 Billion JPY | -5.26% |
| 2019 Q2 | 1.28 Billion JPY | 4.17% |
| 2019 Q3 | 1.39 Billion JPY | 8.51% |
| 2018 FY | 1.3 Billion JPY | 25.09% |
| 2018 Q2 | 1.28 Billion JPY | 6.65% |
| 2018 Q1 | 1.2 Billion JPY | 16.05% |
| 2018 Q4 | 1.3 Billion JPY | 8.55% |
| 2018 Q3 | 1.2 Billion JPY | -6.89% |
| 2017 FY | 1.04 Billion JPY | 36.92% |
| 2017 Q4 | 1.04 Billion JPY | 16.0% |
| 2017 Q3 | 897.81 Million JPY | -5.43% |
| 2017 Q2 | 949.34 Million JPY | 11.75% |
| 2017 Q1 | 849.51 Million JPY | 11.69% |
| 2016 Q3 | 591.93 Million JPY | -0.44% |
| 2016 FY | 760.63 Million JPY | 86.49% |
| 2016 Q1 | 472.37 Million JPY | 15.82% |
| 2016 Q2 | 594.53 Million JPY | 25.86% |
| 2016 Q4 | 760.63 Million JPY | 28.5% |
| 2015 FY | 407.85 Million JPY | 11.78% |
| 2015 Q4 | 407.85 Million JPY | 0.45% |
| 2015 Q3 | 406.03 Million JPY | -1.89% |
| 2015 Q2 | 413.87 Million JPY | -4.94% |
| 2015 Q1 | 435.38 Million JPY | 19.33% |
| 2014 FY | 364.87 Million JPY | 1.52% |
| 2014 Q3 | 355.21 Million JPY | -6.89% |
| 2014 Q4 | 364.87 Million JPY | 2.72% |
| 2014 Q2 | 381.49 Million JPY | 0.64% |
| 2014 Q1 | 379.05 Million JPY | 5.47% |
| 2013 Q1 | 315.46 Million JPY | 17.17% |
| 2013 Q4 | 359.41 Million JPY | 8.92% |
| 2013 Q3 | 329.96 Million JPY | 10.02% |
| 2013 Q2 | 299.9 Million JPY | -4.93% |
| 2013 FY | 359.41 Million JPY | 33.49% |
| 2012 Q1 | 239.7 Million JPY | 6.14% |
| 2012 Q3 | 253.77 Million JPY | 8.78% |
| 2012 Q4 | 269.24 Million JPY | 6.1% |
| 2012 Q2 | 233.3 Million JPY | -2.67% |
| 2012 FY | 269.24 Million JPY | 19.22% |
| 2011 FY | 225.83 Million JPY | 18.81% |
| 2011 Q2 | 215 Million JPY | 2.21% |
| 2011 Q1 | 210.35 Million JPY | 10.67% |
| 2011 Q3 | 221.34 Million JPY | 2.95% |
| 2011 Q4 | 225.83 Million JPY | 2.03% |
| 2010 Q3 | 163.8 Million JPY | 10.18% |
| 2010 FY | 190.07 Million JPY | -12.49% |
| 2010 Q2 | 148.67 Million JPY | -32.21% |
| 2010 Q4 | 190.07 Million JPY | 16.04% |
| 2010 Q1 | 219.32 Million JPY | 0.97% |
| 2009 Q2 | 264.95 Million JPY | -7.65% |
| 2009 Q4 | 217.21 Million JPY | -7.7% |
| 2009 Q3 | 235.34 Million JPY | -11.18% |
| 2009 Q1 | 286.88 Million JPY | 0.06% |
| 2009 FY | 217.21 Million JPY | -24.25% |
| 2008 Q2 | 400.43 Million JPY | 0.0% |
| 2008 FY | 286.73 Million JPY | 0.0% |
| 2008 Q4 | 286.73 Million JPY | -32.53% |
| 2008 Q3 | 425 Million JPY | 6.14% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | -64.107% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -6151.71% |
| GNI Group Ltd. | 2.33 Billion JPY | 51.907% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 49.685% |
| MEDINET Co., Ltd. | 67.48 Million JPY | -1561.014% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | -982.61% |
| AnGes, Inc. | 1.61 Billion JPY | 30.631% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | -1414.708% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 61.389% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | -248.19% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -609067.935% |
| Carna Biosciences, Inc. | 140.14 Million JPY | -699.821% |
| CanBas Co., Ltd. | 728 Thousand JPY | -153865.522% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | -1175.701% |
| RaQualia Pharma Inc. | 147.93 Million JPY | -657.656% |
| Chiome Bioscience Inc. | 64.1 Million JPY | -1648.435% |
| Kidswell Bio Corporation | 875.65 Million JPY | -28.004% |
| PeptiDream Inc. | 2.4 Billion JPY | 53.378% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -20882.198% |
| Ribomic Inc. | 2.27 Million JPY | -49190.633% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -112086899900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -3013.525% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -3765.066% |
| CellSource Co., Ltd. | 305.92 Million JPY | -266.387% |
| FunPep Company Limited | 25.54 Million JPY | -4288.509% |
| Kringle Pharma, Inc. | 364.05 Million JPY | -207.884% |
| Stella Pharma Corporation | 1.11 Billion JPY | -0.413% |
| TMS Co., Ltd. | 50.02 Million JPY | -2140.618% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -5262.753% |
| Cuorips Inc. | 1.04 Million JPY | -107365.868% |
| K Pharma,Inc. | 10.79 Million JPY | -10284.186% |
| Takara Bio Inc. | 11.85 Billion JPY | 90.541% |
| ReproCELL Incorporated | 248.14 Million JPY | -351.708% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | -148.758% |
| StemCell Institute Inc. | 42.26 Million JPY | -2552.191% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | -390.394% |
| CellSeed Inc. | 46.19 Million JPY | -2326.596% |